Ishara Investments’s Amicus Therapeutics FOLD Stock Holding History

Ishara Investments’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-369,000	Closed	-$5.34M	–	46
2026 Q1	$5.34M	Buy	369,000 +9,000	+3%	+$129K	5.05%	6
2025 Q4	$5.13M	Buy	+360,000	New	+$3.54M	5.86%	4

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Ishara Investments's FOLD Position: Q2 2026 in Review

Ishara Investments sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 369,000 shares — an estimated $5.34M sold.

Ishara Investments first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $5.34M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Ishara Investments reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Ishara Investments sold 369,000 Amicus Therapeutics shares in Q2 2026, an estimated $5.34M.
Ishara Investments first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Ishara Investments's Amicus Therapeutics position peaked at $5.34M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.